Published on in Vol 23, No 12 (2021): December
![Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification Mechanism Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification Mechanism](https://asset.jmir.pub/assets/d54c3212a1ca0780abe9b8d05353bf4f.png 480w,https://asset.jmir.pub/assets/d54c3212a1ca0780abe9b8d05353bf4f.png 960w,https://asset.jmir.pub/assets/d54c3212a1ca0780abe9b8d05353bf4f.png 1920w,https://asset.jmir.pub/assets/d54c3212a1ca0780abe9b8d05353bf4f.png 2500w)
1 Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, United States
2 Sean M Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, United States
3 Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, United States
4 Department of Neurology, Columbia University College of Physicians and Surgeons, New York City, NY, United States
5 Department of Neurology, Duke University School of Medicine, Durham, NC, United States